Quick Summary

Cinnamon (Cinnamomum verum) is a botanical spice with preliminary evidence suggesting potential benefits in modulating metabolic parameters associated with type 2 diabetes and cardiovascular risk factors. It is traditionally used as part of polyherbal formulations for liver health and has shown some promise as an antimicrobial and antifungal agent. However, clinical evidence is mixed with some studies showing benefit and others showing limited or no significant effects. Safety data suggest cinnamon is generally well tolerated in clinical trials without significant adverse effects compared to placebo, but data on drug interactions and use in pregnancy are limited. Further well-designed clinical trials are needed to confirm efficacy and safety, clarify optimal dosing, and explore mechanistic pathways.

What is it?

Cinnamon is a spice derived from the inner bark of trees belonging to the genus Cinnamomum. Cinnamomum verum—often referred to as “true cinnamon”—is widely used as a flavoring agent and has been investigated for potential medicinal properties.

Traditional Uses

  • Part of traditional polyherbal remedies for supporting liver health.
  • Used historically for gastrointestinal discomfort and respiratory conditions.
  • Employed in traditional medicine systems for antimicrobial purposes.

Active Compounds

The primary bioactive constituents include cinnamaldehyde, cinnamic acid, eugenol, and various essential oils, which are believed to contribute to the biological activities attributed to cinnamon.

Potential Benefits with Evidence Levels

  • Metabolic outcomes in type 2 diabetes and metabolic syndrome

    Evidence level: Moderate clinical evidence from systematic reviews and meta-analyses of randomized controlled trials

    Meta-analyses suggest cinnamon supplementation may improve fasting blood glucose, HbA1c, insulin resistance (HOMA-IR), fasting insulin, and lipid profiles including LDL cholesterol, triglycerides, and increase HDL cholesterol. Effects may be dose- and time-dependent, though variability and heterogeneity exist among studies.
  • Cardiovascular risk factors

    Evidence level: Moderate clinical evidence from meta-analyses

    Cinnamon supplementation has been associated with reductions in waist circumference, systolic and diastolic blood pressure, and C-reactive protein, along with improvements in lipid profiles, suggesting potential cardiovascular benefits.
  • Polycystic ovary syndrome (PCOS)

    Evidence level: Limited clinical evidence from small RCTs and pilot studies

    Some evidence indicates cinnamon may reduce ovarian volume and abdominal subcutaneous fat in women with PCOS, but no significant effects on insulin resistance, androgen levels, or lipid profiles have been consistently observed.
  • Oral health (nasal irrigation in allergic rhinitis)

    Evidence level: Low clinical evidence from network meta-analyses

    Cinnamon bark nasal irrigation showed potential in improving quality of life for allergic rhinitis patients, though data remain limited and require further validation.
  • Antimicrobial activity

    Evidence level: Preclinical evidence

    In vitro and animal studies demonstrate antimicrobial and antifungal activities of cinnamon essential oils and extracts against various pathogens, including resistant bacteria and fungi. Clinical data are lacking.
  • Hepatoprotection

    Evidence level: Preclinical and limited clinical evidence

    Cinnamon is used in some polyherbal formulations with preliminary evidence suggesting possible hepatoprotective effects through modulation of liver enzymes and inflammatory markers; however, human data are limited.

Side Effects

Cinnamon is generally well tolerated. Mild transient gastrointestinal symptoms such as discomfort or upset stomach have been reported in some trials. No serious or dose-limiting toxicities have been consistently documented in clinical studies.

Drug Interactions

There is insufficient clinical evidence to conclusively characterize drug interactions with cinnamon. Due to its potential blood glucose-lowering effects, caution is advised when cinnamon is taken alongside antidiabetic medications because of possible additive hypoglycemic effects. Further research is needed.

Who Should Avoid It

  • Individuals on glycemic control medications should use cinnamon cautiously to avoid additive blood sugar lowering.
  • Pregnant and breastfeeding women should exercise caution due to lack of robust safety data and use only under professional supervision.
  • No other well-established contraindications are currently known based on available clinical data.

Evidence Limitations

The body of evidence regarding cinnamon’s efficacy and safety is heterogeneous, with variability in study quality, sample sizes, dosing regimens, treatment durations, and patient populations. Many clinical studies have small sample groups, short follow-up periods, and potential biases. Preclinical findings should not be directly extrapolated to humans. More rigorous, large-scale, and long-term randomized controlled trials are necessary to better establish efficacy, safety, optimal dosing, and potential pharmacological interactions.

References

Last Reviewed

June 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you have underlying health conditions or are taking medications.